Stay updated with breaking news from Initial Statements. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Transaction Delivers KarXT, a First-in-Class M1 / M4 Muscarinic Receptor Agonist, with Differentiated Efficacy and Safety KarXT Is a Potential First-in-Class Treatment for Schizophrenia and as an...
Files Definitive Proxy Urges Shareholders to Protect Their Investments by Voting FOR the Proposed Transaction ...
Consolidated Communications Holdings, Inc. , a top 10 fiber provider in the U.S., today reported results for the third quarter of 2023. Third Quarter 2023 Results Revenue totaled $283.7...
Highlights AIM’s Significant Momentum and Ongoing Achievement of Clinical and Regulatory Milestones Urges Shareholders to Protect AIM’s Progress by Voting for the Company’s Board of Directors...
/PRNewswire/ -- Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial stage biotechnology company, today announced financial results for the third quarter...